Gyre Therapeutics Inc (GYRE)
8.75 x 2 10.50 x 60
Pre-market by (Cboe BZX)
9.09 +0.30 (+3.41%) 03/27/25 [NASDAQ]
8.75 x 2 10.50 x 60
Pre-market 8.94 -0.15 (-1.65%) 06:48 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | GYRE | NTLA | OCS | ||
| Company | Gyre Therapeutics Inc | Intellia Thera CS | Oculis Holding Ag | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.94 | 8.35 | 19.77 | ||
| High | 8.94 | 8.35 | 19.77 | ||
| Low | 8.94 | 8.35 | 19.08 | ||
| Last | 8.94 | 8.35 | 19.40 | ||
| Change | -0.15 | -0.05 | -0.26 | ||
| % Change | -1.65% | -0.60% | -1.32% | ||
| Volume | 619 | 10,321 | 36,500 | ||
| 20-Day Average Volume | 206,066 | 3,046,516 | 43,430 | ||
| Previous Close | 9.09 | 8.40 | 19.66 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.42 | 9.19 | 19.04 | ||
| 20-Day Raw Stochastic | 8.64% | 9.34% | 76.10% | ||
| 20-Day Relative Strength | 41.27% | 39.86% | 47.59% | ||
| Weighted Alpha | -44.94 | -69.03 | +63.29 | ||
| Today's Opinion | 100% Sell | 100% Sell | 56% Buy | ||
| Previous Opinion | 100% Sell | 100% Sell | 56% Buy | ||
| Last Month's Opinion | 80% Sell | 72% Sell | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.93% since 03/21/25 | -7.22% since 03/21/25 | -1.22% since 03/20/25 | ||
| Low | 8.65 on 03/26/25 | 8.11 on 03/27/25 | 19.08 on 03/27/25 | ||
| High | 9.98 on 03/24/25 | 9.38 on 03/24/25 | 20.00 on 03/26/25 | ||
| 1-Month | |||||
| %Chg | -22.93% since 02/28/25 | -17.24% since 02/28/25 | -1.42% since 02/27/25 | ||
| Low | 8.48 on 03/18/25 | 8.11 on 03/27/25 | 17.49 on 03/12/25 | ||
| High | 13.75 on 03/07/25 | 10.68 on 03/07/25 | 20.00 on 03/26/25 | ||
| 3-Month | |||||
| %Chg | -28.19% since 12/27/24 | -30.24% since 12/27/24 | +14.39% since 12/27/24 | ||
| Low | 8.48 on 03/18/25 | 8.11 on 03/27/25 | 16.88 on 12/30/24 | ||
| High | 13.75 on 03/07/25 | 13.34 on 01/07/25 | 23.08 on 01/13/25 | ||
| 6-Month | |||||
| %Chg | -29.94% since 09/27/24 | -60.24% since 09/27/24 | +57.57% since 09/27/24 | ||
| Low | 8.48 on 03/18/25 | 8.11 on 03/27/25 | 12.08 on 10/01/24 | ||
| High | 19.00 on 11/12/24 | 21.47 on 10/18/24 | 23.08 on 01/13/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 850,933 | 869,543 | 847,043 | ||
| Shares Outstanding, K | 93,612 | 103,517 | 43,662 | ||
| Annual Sales | 105,760,000 | 57,880,000 | 780,000 | ||
| Annual Net Income | 12,090,000 | -519,020,000 | -97,430,000 | ||
| Last Quarter Sales | 27,870,000 | 12,870,000 | 250,000 | ||
| Last Quarter Net Income | -100,000 | -128,900,000 | -23,330,000 | ||
| 60-Month Beta | 1.93 | 1.97 | 0.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 03/17/25 | -1.24 on 02/27/25 | -0.76 on 03/11/25 | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 05/14/25 | ||
| Most Recent Dividend | 0.569 on 08/20/15 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 109.88 | 0.00 | 0.00 | ||